- Home
- DVN vs VTR Comparison
DVN vs VTR Comparison
Compare DVN & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVN
- VTR
- Stock Information
- Founded
- DVN 1971
- VTR 1983
- Country
- DVN United States
- VTR United States
- Employees
- DVN N/A
- VTR N/A
- Industry
- DVN Oil & Gas Production
- VTR Real Estate Investment Trusts
- Sector
- DVN Energy
- VTR Real Estate
- Exchange
- DVN Nasdaq
- VTR Nasdaq
- Market Cap
- DVN 25.4B
- VTR 27.3B
- IPO Year
- DVN N/A
- VTR 1998
- Fundamental
- Price
- DVN $37.58
- VTR $62.81
- Analyst Decision
- DVN Buy
- VTR Buy
- Analyst Count
- DVN 21
- VTR 10
- Target Price
- DVN $51.47
- VTR $60.40
- AVG Volume (30 Days)
- DVN 8.4M
- VTR 2.6M
- Earning Date
- DVN 11-05-2024
- VTR 10-30-2024
- Dividend Yield
- DVN 3.86%
- VTR 2.86%
- EPS Growth
- DVN N/A
- VTR N/A
- EPS
- DVN 5.41
- VTR N/A
- Revenue
- DVN $14,529,000,000.00
- VTR $4,797,115,000.00
- Revenue This Year
- DVN $9.80
- VTR N/A
- Revenue Next Year
- DVN $8.11
- VTR $7.07
- P/E Ratio
- DVN $6.95
- VTR N/A
- Revenue Growth
- DVN N/A
- VTR 10.05
- 52 Week Low
- DVN $37.15
- VTR $41.45
- 52 Week High
- DVN $55.09
- VTR $67.61
- Technical
- Relative Strength Index (RSI)
- DVN 40.27
- VTR 43.15
- Support Level
- DVN $37.15
- VTR $61.73
- Resistance Level
- DVN $38.37
- VTR $65.24
- Average True Range (ATR)
- DVN 0.89
- VTR 0.96
- MACD
- DVN -0.04
- VTR -0.16
- Stochastic Oscillator
- DVN 16.60
- VTR 29.21
About DVN Devon Energy Corporation
Devon Energy is an oil and gas producer with acreage in several top US shale plays. While roughly two thirds of its production comes from the Permian Basin, it also holds a meaningful presence in the Anadarko, Eagle Ford, and Bakken basins. At the end of 2023, Devon reported net proved reserves of 1.8 billion barrels of oil equivalent. Net production averaged roughly 658,000 barrels of oil equivalent per day in 2023 at a ratio of 73% oil and natural gas liquids and 27% natural gas.
About VTR Ventas Inc.
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.